An interventional study of PureVision 1 and PureVision 2 in Myopia, sponsored by Bausch & Lomb Incorporated. Completed at 1 site in Japan. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2013-03-18.
Sponsored by Bausch & Lomb Incorporated · Not applicable, Interventional, and Screening
To evaluate the wearing satisfaction of a new design of the PureVision soft contact lenses.
984 studies on the registry are indexed under Myopia; 210 are open to participants now.
This study's enrollment of 64 is below the median of 80 across 783 interventional studies indexed under Myopia.
Browse Myopia studies →Bausch & Lomb Incorporated is the lead sponsor of 219 studies on the registry; 7 are open to participants now.
Of its 49 completed or terminated interventional studies of FDA-regulated products, 41 (84%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
PureVision soft contact lens design #1.
Device: PureVision 1
PureVision soft contact lens design #2
Device: PureVision 2
Currently marketed PureVision soft contact lens.
Alternate design soft contact lens.
Patient satisfaction
Time frame: 4 weeks
This study is completed, as verified in Mar 2013. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bausch & Lomb Incorporated